ONCO
Price
$4.83
Change
+$0.18 (+3.87%)
Updated
Jun 27 closing price
Capitalization
2.52M
43 days until earnings call
OPORF
Price
$0.24
Change
-$0.05 (-17.24%)
Updated
Feb 14 closing price
Capitalization
109.61M
Interact to see
Advertisement

ONCO vs OPORF

Header iconONCO vs OPORF Comparison
Open Charts ONCO vs OPORFBanner chart's image
Onconetix
Price$4.83
Change+$0.18 (+3.87%)
Volume$219.65K
Capitalization2.52M
OPEN ORPHAN
Price$0.24
Change-$0.05 (-17.24%)
Volume$3K
Capitalization109.61M
ONCO vs OPORF Comparison Chart in %
Loading...
ONCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ONCO vs. OPORF commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ONCO is a Hold and OPORF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (ONCO: $4.83 vs. OPORF: $0.24)
Brand notoriety: ONCO and OPORF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ONCO: 63% vs. OPORF: 100%
Market capitalization -- ONCO: $2.52M vs. OPORF: $109.61M
ONCO [@Biotechnology] is valued at $2.52M. OPORF’s [@Biotechnology] market capitalization is $109.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ONCO’s FA Score shows that 1 FA rating(s) are green whileOPORF’s FA Score has 1 green FA rating(s).

  • ONCO’s FA Score: 1 green, 4 red.
  • OPORF’s FA Score: 1 green, 4 red.
According to our system of comparison, OPORF is a better buy in the long-term than ONCO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ONCO’s TA Score shows that 4 TA indicator(s) are bullish.

  • ONCO’s TA Score: 4 bullish, 6 bearish.

Price Growth

ONCO (@Biotechnology) experienced а +15.27% price change this week, while OPORF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ONCO is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OPORF($110M) has a higher market cap than ONCO($2.52M). OPORF YTD gains are higher at: -34.871 vs. ONCO (-90.980).
ONCOOPORFONCO / OPORF
Capitalization2.52M110M2%
EBITDAN/AN/A-
Gain YTD-90.980-34.871261%
P/E RatioN/A11.75-
RevenueN/AN/A-
Total Cash341KN/A-
Total Debt10.1MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ONCOOPORF
RSI
ODDS (%)
Bullish Trend 3 days ago
74%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
14%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
14%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ONCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVEX6.690.76
+12.82%
Eve Holding
UFG2.290.07
+3.15%
Uni-Fuels Holdings Ltd
ADTN8.890.13
+1.48%
ADTRAN Holdings
CPT113.76-0.57
-0.50%
Camden Property Trust
TAOP4.40-0.12
-2.65%
Taoping Inc

ONCO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONCO has been loosely correlated with OPORF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ONCO jumps, then OPORF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONCO
1D Price
Change %
ONCO100%
+3.87%
OPORF - ONCO
47%
Loosely correlated
N/A
INO - ONCO
43%
Loosely correlated
-6.22%
PCSA - ONCO
34%
Loosely correlated
-17.63%
INSM - ONCO
30%
Poorly correlated
-5.11%
EVAX - ONCO
30%
Poorly correlated
-5.41%
More

OPORF and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPORF has been loosely correlated with KURA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if OPORF jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPORF
1D Price
Change %
OPORF100%
N/A
KURA - OPORF
62%
Loosely correlated
-1.05%
EVAX - OPORF
53%
Loosely correlated
-5.41%
PCSA - OPORF
51%
Loosely correlated
-17.63%
VERA - OPORF
50%
Loosely correlated
-2.75%
ONCO - OPORF
47%
Loosely correlated
+3.87%
More